Health Condition 1: M432- Fusion of spine
Conditions
Interventions
Intervention1: Comparision of two adjuvants: Group RD will receive 0.2% ropivacaine (38 ml) and 1 mcg/kg ideal body weight of dexmedetomidine (in a volume of 2 ml), at the time of surgical wound closu
Sponsors
Dr Sandeep Dey
Eligibility
Inclusion criteria
Inclusion criteria: 1. American Society of Anesthesiologists (ASA) I/II. 2. Elective thoracolumbar spinal fusion surgery. 3. Patients giving written informed consent for study.
Exclusion criteria
Exclusion criteria: 1. Known allergy to study drugs. 2. Presence of severe uncontrolled renal, liver, cerebrovascular or cardiovascular disease. 3. Chronic beta blocker treatment with heart rate or preoperative HR 4. Patients with psychiatric illness, low GCS ( 5. Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the total opioid consumption in the first 24-hours post-operative period between the groups.Timepoint: At the end of surgery and final evaluation after 1 year. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the post operative analgesia (using visual analogue scale) between the groups.Timepoint: At the end of surgery and final evaluation after 1 year.;To compare the side effect profile between the groups.Timepoint: At the end of surgery and final evaluation after 1 year.;To compare the time of the first request for rescue analgesia between the groupsTimepoint: At the end of surgery and final evaluation after 1 year. | — |
Countries
India
Contacts
Public ContactDr Mukesh Mohan Gupta
Paras Hospitals, Gorgaon
Outcome results
None listed